Terkis I. Pavel
Erciyes, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Modified mRNA Encoding the Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein Confers Robust Protection Against Lethal Challenge in Mice.
Journal: Journal of medical virology
Published: August 28, 2025
Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months.
Journal: Frontiers in medicine
Published: November 07, 2024
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.
Journal: Vaccines
Published: January 14, 2024
SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants.
Journal: Frontiers in plant science
Published: September 06, 2023
Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants.
Journal: Frontiers in plant science
Published: April 08, 2023
Development of an Inactivated Vaccine against SARS CoV-2.
Journal: Vaccines
Published: October 05, 2021
Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.
Journal: PloS one
Published: May 05, 2020
Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
Journal: PLoS neglected tropical diseases
Published: February 07, 2020
Francisella is sensitive to insect antimicrobial peptides.
Journal: Journal of innate immunity
Published: March 22, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026